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Abstract
OBJECTIVE: To observe the effect of tribulus terres-
tris saponins (TTS) on behavior and neuroendo-
crine of chronic mild stress (CMS) depression rats.
METHODS:ThirtymaleSprague-Dawleyratswereran-
domly allocated to six groups: vehicle group, CMS
group, CMS + fluoxetine group and CMS + TTS of
low-dosage(0.375g/kg),medium-dosage(0.75g/kg)
and high-dosage (2.25 g/kg) groups. All rats except
the vehicle group singly housed and exposed an
unpredicted sequence of mild stressors. The behav-
ior of rats was detected by open-field test (OFT)
and sucrose preference test (SPT). The concentra-
tion of corticotropin-releasing factor (CRF) and ad-
renocorticotropic hormone (ACTH) in serum of the
rats were detected by radioimmunoassay. The con-
centration of cortisol (CORT) in serum was detected
by enzyme immunoassay.
RESULTS: CMS procedure not only significantly de-
creased the scores of crossing, rears and grooming
in OFT and the sucrose preference in SPT (all P<
0.01), but also markedly increased serum CRH and
CORT levels (both P<0.05). Treatment with TTS (0.75
and 2.25 g/kg) could significantly prevent all of
these abnormalities induced by CMS (P<0.05, P<
0.01).
CONCLUSION: CMS can affect rat behavior and
neuroendocrine and cause depression. TTS has the
antagonism on CMS and produce antidepressive ef-
fects.
© 2013 JTCM. All rights reserved.
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INTRODUCTION
Depression is a disorder that has high incidence in the
world population with impact in life quality of pa-
tients.1 The treatment of depression with conventional
antidepressants provides a complete remission just for
50% of the individuals, and produces side effects that
may reduce adhesion of patients to the treatment.2
Thus, traditional drug (including natural medicine,
Chinese herbal medicine) or additional treatments
with low side effects and costs are of particular interest.3
Lots of evidence has suggested that an association be-
tween depressive disorders and neuroendocrine altera-
tions, hyperactivity of the hypothalamic-pituitary-adre-
nal (HPA) is thought to be involved in the pathogene-
sis of depression.4 It has also been demonstrated that
antidepressant treatment could normalize the HPA axis
hyperactivity in depressed patients.5 Corticotropin-re-
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leasing factor (CRF), adrenocorticotropic hormone
(ACTH) and cortisol (CORT) are key mediators of the
mammalian response to stress stimuli, involving in the
HPA axis dysfunction.6 Our previous studies indicated
that traditional Chinese herbal decoction which main-
ly contain tribulus terrestris had an antidepressant-like
activity in the depression animals and patients.7,8 The
present study observe the effect of tribulus terrestris sa-
ponins (TTS) which is main effective components
from tribulus terrestris on behavior and neuroendo-
crine of chronic mild stress (CMS) depression rats.
MATERIALS ANDMETHODS
Drugs and instruments
TTS was purchased from Hunan Sanwei Medical Tech-
nology Co. Ltd. (Hunan, China). The purity of Sapo-
nins was 80% . Fluoxetine hydrochloride was from
Changzhou Siyao Pharmaceuticals Co., Ltd. (Chang-
zhou, China, lot No. 211021). CRF and ACTH radio-
immunoassay kits were purchased from Beijing North
Institute of Biological Technology (Beijing, China).
CORT enzyme immunoassay (magnetic solid phase)
kits were purchased from Beijing Bio-Ekon Biotechnol-
ogy Co. Ltd. (Beijing, China). The procedure was per-
formed as described by the kit's manufacturer, respec-
tively. Other reagents were analytical grades made in
China.
Experimental animals
Sprague Dawley (SD) male rats, six month old, weigh-
ing (200±20) g, were provided by Sino-British Sippr/
bk Lab. Animal Co. Ltd., with certificate number:
SCXK (Shanghai) 2008-0003. Animals were allowed
to adapt one week before the experiment started. All rats
were individually housed (cage size: 30 cm × 20 cm ×
16 cm), with food and water freely available, and main-
tained on a 12 h dark-light cycle (with the lights on at
07:00 h locate time) under regulated temperature con-
ditions (22℃ ± 2℃ ), except as described below. The
study was approved by the institutional Animal Care
Committee at the Central South University.
CMS
The CMS procedure was slightly modified from that
previously described.8,9 Briefly, the weekly stress regime
consisted of food and water deprivation, stroboscopic
illumination (150 flashes/min), white noise, light/dark
succession every 2 h, overnight illumination, 45° cage
tilt, soiled cage and pair-housing. All stressors were ap-
plied individually and continuously. The vehicle rats
were housed in a separate room and had no contact
with stressed animals. These rats were deprived of food
and water for 18 h preceding each sucrose preference
test (SPT), but otherwise food and water were freely
available in the home cage. The CMS procedure was
last for 4 weeks.
The animals were randomly divided into 6 groups (5
rats per group): vehicle group, CMS group, CMS-
fluoxetine group (1.8 mg/kg, corresponding to an
adult clinical dose), and CMS-TTS at dose of low-dos-
age (0.375 g/kg), medium-dosage (0.75 g/kg, corre-
sponding to an adult clinical dose) and high-dosage
group (2.25 g/kg). Five groups except vehicle were ex-
posed to the CMS procedure for 4 weeks. All drugs
were suspended in fresh water, and administered by ga-
vage once daily at 11:00 am for 4 weeks.
SPT
Special experimental procedures were conducted in ac-
cordance with the previous literature.9,10 SPT as em-
ployed previously was used to operationally define an-
hedonia. Speciﬁcally, anhedonia was deﬁned as a reduc-
tion in sucrose intake and sucrose preference. Rats
were first trained to consume 1% (v/v) sucrose solution
for 48 h without food and water supply. Three days lat-
er, the sucrose baseline test was performed following
18 h of food and water deprivation. Rats were allowed
to choose from two bottles, one with 1% sucrose solu-
tion and the other with water, for 1 h. Sucrose and wa-
ter intake was recorded, and sucrose preference (SP)
was calculated as SP (%)=sucrose intake (mL)/ [sucrose
intake (mL)+water intake (mL)]×100%. Following ex-
posure to 4 weeks of stress, SPT was repeated using the
same procedure.
Open-field test (OFT)
The ambulatory behavior was assessed in an OFT as
previously described.9 Open field arena used was a
wooden box (77 cm×77 cm×40 cm) with the floor di-
vided into 49 equal squares. At the start of each trial, a
mouse was placed in the central square of the field and
was allowed to freely explore the arena. The scores of
crossing, scores of rears, time of staying in the central
square and time of grooming were counted in a 6 min
session. The arena floor was cleaned between the trials
with a 10% ethanol solution and the test was carried
out in a temperature, noise and light controlled room.
OFT as employed previously was used to define loco-
motor activity.
Blood sample collection
After the CMS period and post-CMS sucrose intake
test, rats were left without any treatment until the fol-
lowing morning. To avoid fluctuations on hormone
concentrations due to circadian rhythms, animals were
sacrificed via decapitation between the hours of 09:00
and 10:00 on two consecutive days. Blood was collect-
ed in pre-iced tubes with protease inhibitor aprotinin
and centrifuged at 3000 rpm at 4℃ for 20 min. The
separated serum samples were stored at −80℃ until the
assay of CRF, ACTH, and CORT.
Statistical analyses
SPSS 18.0 sofeware (SPSS Inc, Chicago, IL, USA) was
used to analyze the data. All data are expressed as
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mean±SD. The statistical significance was analyzed by
Student's t-test or analysis of variance with Bonferroni
for post hoc comparison. A value of P<0.05 was con-
sidered statistically significant for analysis.
RESULTS
Effect of TTS on body quality and OFT
As shown in Table 1, before CMS (day 0), there was
no difference between vehicle group and drug (TTS or
fluoxetine)-treated groups in the body quality and each
index scale measurement in OFT (all P>0.05). After ex-
posed to chronic mild stressors (day 29), compared
with vehicle group, the CMS group rats decreased
body weight significantly (P<0.01), markedly reduced
scores of crossing, rears and time of grooming, in-
creased time of staying in central square in OFT (all P<
0.01), which suggested that chronic stress could affect
body weight and behavior of rats. After 4 weeks treat-
ment, the body weight and all records in the OFT of
the CMS-treated rats in TTS at 0.75 and 2.25 g/kg
groups have significantly improved (P<0.01). More-
over, this parameter was also significantly increased by
the chronic administration of fluoxetine. TTS at
0.375 g/kg could slightly but not remarkably improve
body weight and the records of OFT in the CMS-treat-
ed rats (all P>0.05). It is suggested that TTS at 0.75
and 2.25 g/kg could improve body weight and behav-
ior of depressive rats.
Effect of TTS on SPT
As shown in Table 1, there was no difference between
vehicle group and drug (TTS or fluoxetine)-treated
groups before CMS (P>0.05). After exposed to CMS
for 4 weeks (day 29), compared with vehicle group, the
CMS group rats decreased sucrose preference signifi-
cantly (P<0.01). In the CMS-TTS treated groups (0.75
and 2.25 g/kg), it significantly elevated the sucrose
preference of stressed rats after 4-week treatment (P<
0.01). Fluoxetine remarkably improved CMS-induced
sucrose preference (P<0.01), but TTS at 0.375 g/kg
failed to significantly alter this (P>0.05).
Effect of TTS on serum CRF levels
As shown in Table 2, Compared with vehicle group,
the CMS procedure induced serum CRF levels of mod-
el rats a significantly higher (P<0.05). After 4-week
treatment, TTS at 0.75 and 2.25 g/kg significantly re-
duced serum CRF levels in the stressed animals (P<
0.05). Fluoxetine also produced a significant reduce in
serum CRF levels (P<0.05). However, TTS at 0.375 g/
kg was failed to alter serum CRF levels in the stressed
animals.
Effect of TTS on Serum ACTH Levels
As shown in Table 2, CMS produced no change in se-
rum ACTH concentrations between the stressed ani-
mals and corresponding vehicle groups (P>0.1). There
was no significant interaction between the TTS treat-
ment and CMS groups (P>0.1), and same as fluoxetine
treatment.
Effect of TTS on serum CORT Llevels
As shown in Table 2, Compared with vehicle group,
Table 1 Behaviors and body weight before CMS and post-treatment in rats (n=5, xˉ ± s )
Notes: CMS: chronic mild stress; TTS: tribulus terrestris saponins; OFT: open-field test; SPT: sucrose preference test. Compare with the
model group,aP<0.05,bP<0.01.
Group
Vehicle
CMS
CMS-
Fluoxetine
CMS-
TTS (low)
CMS-
TTS (mid)
CMS-
TTS (high)
Day 0
Day 29
Day 0
Day 29
Day 0
Day 29
Day 0
Day 29
Day 0
Day 29
Day 0
Day 29
Weight (g)
208.6±11.4
316.1±22.4a
205.8±10.8
265.4±20.8
206.4±12.3
298.5±23.4a
207.5±11.4
269.5±20.9
204.8±10.6
287.8±18.6b
209.9±10.6
300.5±25.7a
OFT
Score of
crossing
68.1±13.8
69.4±12.2a
70.2±12.9
19.7±7.9
69.5±18.5
45.7±17.9a
71.3±13.3
21.9±8.3
68.7±14.8
44.9±17.6a
72.3±14.7
54.8±16.4a
6.8±2.1
14.9±9.2
11.8±3.1a
14.9±7.6
12.5±2.9a
Score of rears
15.1±6.1
13.9±8.1a
14.4±9.1
5.3±1.7
15.5±7.8
12.1±3.8a
15.1±8.7
5.6±1.3
0.0±0.0
2.0±1.6a
0.0±0.0
1.7±0.8a
Time of staying
in central square
(s)
0.0±0.0
0.0±0.0a
0.0±0.0
6.4±2.1
0.0±0.0
1.8±0.9a
0.0±0.0
3.1±1.3
8.3±3.8
7.1±3.2a
8.9±3.5
7.8±2.4a
Time of
grooming
(s)
8.5±3.8
9.4±2.5a
9.1±4.6
2.7±1.2
7.8±3.1
6.2±2.9a
8.7±3.6
34.6±3.7
46.8±4.4
48.2±3.5a
46.1±4.3
46.6±3.9a
SPT
Sucrose
preference (%)
46.2±4.6
48.3±3.9a
45.7±2.7
32.6±5.6
46.6±4.9
48.6±4.4a
46.6±5.7
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there was a significant increase in CORT levels in
CMS rats (P<0.05).TTS at 0.375 g/kg slightly but not re-
markably reduced serumCORT levels in the CMS-treat-
ed rats (P>0.05), and TTS at 0.75and 2.25 g/kg signifi-
cantly attenuated the CMS-induced increase in CORT
levels (P<0.05). Fluoxetine exhibited a tendency to sig-
nificantly decrease these levels of CMS-treated animals
(P<0.05).
DISCUSSION
Depression is a common, debilitating, life-threatening
illness with an increasing morbidity and mortality.
World Health Organization revealed that depression is
the fourth leading cause of disability worldwide.11 De-
pression belongs to the category of Yu-disease in Tradi-
tional Chinese Medicine (TCM). Analysis of TCM dif-
ferent syndromes composition ratio in depression pa-
tients find that the most common TCM syndromes of
depression is called stagnation of liver-Qi.12 Sentiment
abnormality and stagnation of liver-Qi are thought to
be involved in pathogenesis of depression in TCM, and
the basic principles of treatment is dispersing stagnated
liver Qi for relieving Qi stagnation. Tribulus terrestris
is a flowering plant in the family zygophyllaceae, and
its dry fruit is widely used in traditional Chinese for-
mulations for dispelling wind-evil and melancholy. Tra-
ditional Chinese herbal decoction which mainly con-
tains tribulus terrestris has been previously confirmed
to have an antidepressant-like activity in depression ani-
mal and patients.7,8 TTS are the main effective compo-
nents isolated from tribulus terrestris. Thus, it is neces-
sary to further explore TTS antidepressant effect.
Chronic stress is an important factor in depression,
and changes in various body systems that occurred in
depression are similar to those observed in response to
stress.13 CMS, the most promising and valuable rodent
model of depression, are widely used to research and
screen for antidepressants. In addition, as proposed by
Willner,9 CMS appears more suitable for studying the
mechanisms of antidepressant drugs. In the CMS pro-
cedure, animals are exposed to different kinds of mild
stress every day, which mimics chronic stressful life
events and results in anhedonia and locomotor activity
decreasing, the core symptoms of human depression.
As a result, these symptoms induced by CMS proce-
dure can be restored by therapeutically effective drugs
for the treatment of depression.9,13 Therefore, we inves-
tigated the antidepressant-like effect and mechanisms
of TTS treatment in this model. Our results found that
CMS can reduced scores of crossing, rears and time of
grooming, increased time of staying in central square
in OFT, decreased body weight and reduced sucrose
preference in SPT, the present result was in agreement
to the findings of other similar studies.9,10 All of these
symptoms induced by CMS procedure was significant-
ly attenuated by chronic treatment with TTS at 0.75
and 2.25 g/kg, but not at 0.375 g/kg, which confirmed
that CMS can affect rats behavior and cause depres-
sion, TTS (0.75 and 2.25 g/kg) can antagonism on it
and has antidepressant-like effects.
It is well known that abnormality of neuroendocrine
function plays an important role in the occurrence of
depression.14The hypothalamic-pituitary-adrenal (HPA)
axis is one of the important neuroendocrine axes, and en-
hanced activity of this axis is considered a key neurobio-
logical alteration in major depression.14,15 CRF, the ma-
jor physiological regulator of HPA system, is believed
to contribute to several depressive symptoms, and aug-
mentation of pituitary, and elevated CORT levels in se-
rum have been observed in depressive disorders.16 On
the other hand, HPA axis hyperactivity is dependent
on a depressed status and it tends to be normalized fol-
lowing alleviation of clinical symptoms after antidepres-
sant treatments.17 Thus normalization of HPA axis ac-
tivity is a cure key and an indication of depression re-
lief. In the present study, the CMS procedure resulted
in increases of serum CRF and CORT in rats, indicat-
ing that CMS might cause HPA axis hyperactivity.
CRF is the most potent ACTH secretagogue, but in
the present study, the CMS procedure rendered no rela-
tive differences on serum ACTH concentrations in
rats. This dissociation between CRF and ACTH was
found in other similar studies.18 These may be due to
the origin of serum CRF was a confounding factor in
these determinations, hence peripheral concentrations
of CRF were difficult to interpret. In this study, we
found TTS at 0.75 and 2.25 g/kg but not at 0.375 g/
kg significantly attenuated the CMS-induced serum
CRF and CORT levels. It supported the hypothesis
that TTS could exert its antidepressant effect by nor-
malizing HPA axis hyperactivity through CRF and
Table 2 Effects of TTS on CRF, CORT and ACTH in serum in the rats (ng/mL, xˉ ± s )
Group
Vehicle
CMS
CMS+Fluoxetine
CMS+TTS (low)
CMS+TTS (mid)
CMS+TTS (high)
n
5
5
5
5
5
5
CRF
2.24±0.37a
4.58±0.49
2.19±0.52a
4.04±0.44
2.38±0.29a
1.97±0.33a
ACTH
49.68±12.62
56.95±16.84
52.72±12.85
56.58±15.72
55.74±14.37
51.89±13.69
CORT
15.86±3.87a
35.68±8.46
23.79±5.16a
30.48±4.52
18.65±3.58a
14.14±3.96a
Notes: CMS: chronic mild stress; TTS: tribulus terrestris saponins; CRF: corticotropin-releasing factor; ACTH: adrenocorticotropic
hormone; CORT: cortisol. Compare with the model group,aP<0.05.
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CORT levels regulation.
In conclusion, the present study demonstrated that
TTS had potentially antidepressant-like activity in
CMS rats. The mechanism involved can be mediated
by HPA axis. TTS may be a favorable alternative to cur-
rently available antidepressant drugs. Further preclini-
cal and clinical experiments are needed to clarify the
role of TTS in contributing to the treatment of depres-
sive disorders.
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